Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

ABBOTT PARK, IL US

1. 20090287257 CERVICAL PLATE - having a plurality of boreholes and one or more openings for aligning or positioning the boreholes on a vertebra 11-19-2009
2. 20090286784 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS 11-19-2009
3. 20090286329 ISOLATED HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES AND METHODS AND KITS FOR DETECTING HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES 11-19-2009
4. 20090286256 ISOLATED HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES AND METHODS AND KITS FOR DETECTING HUMAN AUTOANTIBODIES TO NATRIURETIC PEPTIDES 11-19-2009
5. 20090285881 CATIONIC LIPIDS AND USES THEREOF - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 11-19-2009
6. 20090282932 GAS SCRUBBER FOR AUTOMATED CLINICAL ANALYZER 11-19-2009
7. 20090281582 INSTRUMENT FOR THE REDUCTION OF A ROD INTO POSITION IN A PEDICLE SCREW 11-12-2009
8. 20090281118 Selective Ligands for the Neuronal Nicotinic Receptors and Uses Thereof 11-12-2009
9. 20090280474 METHOD FOR DETECTING A VIRUS - This invention is related a method for increasing the sensitivity of detecting a viral target in a sample 11-12-2009
10. 20090275062 METHOD OF TACROLIMUS EXTRACTION AND QUANTIFICATION USING AQUEOUS DETERGENTS 11-05-2009
11. 20090273121 CLOSURE FOR CONTAINER FOR HOLDING BIOLOGICAL SAMPLES 11-05-2009
12. 20090270424 Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluor- omethyl)phenyl)urea hydrochloride 10-29-2009
13. 20090270408 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF 10-29-2009
14. 20090270364 SUBSTITUTED PYRIMIDINE DERIVATIVES - The present application describes substituted pyrimidine compounds of formula STR00001 wherein X, A 10-29-2009
15. 20090269777 IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL 10-29-2009
16. 20090264480 TRPA1 ANTAGONISTS - Compounds of formula STR00001 wherein R 10-22-2009
17. 20090264437 4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor 10-22-2009
18. 20090263894 ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF 10-22-2009
19. 20090263845 METHOD AND KIT FOR ASSESSING THE SUITABILITY OF ERYTHROCYTES FOR TRANSFUSION 10-22-2009
20. 20090263477 SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF 10-22-2009
21. 20090263407 Cationic Lipids and Uses Thereof - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 10-22-2009
22. 20090258907 COMPOUNDS USEFUL AS INHIBITORS OF ROCK KINASES 10-15-2009
23. 20090253723 PROTEIN KINASE INHIBITORS - Compounds that inhibit protein kinases compositions containing the compounds and methods of treating diseases using the 10-08-2009
24. 20090253678 MACROCYCLIC PYRIMIDINE DERIVATIVES - Macrocyclic pyrimidine compounds compositions comprising such compounds methods for making the compounds 10-08-2009
25. 20090253670 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF 10-08-2009
26. 20090252746 ERYTHROPOIETIN RECEPTOR BINDING ANTIBODIES 10-08-2009
27. 20090252652 Apparatus And Method For Handling Fluids For Analysis 10-08-2009
28. 20090247500 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 10-01-2009
29. 20090246800 IMMUNOASSAY OF ANALYTES IN SAMPLES CONTAINING ENDOGENOUS ANTI-ANALYTE ANTIBODIES 10-01-2009
30. 20090239271 FERMENTATION BROTH EXTRACTION OF K-252A - Methods for separating K-252a from the cell mass of its parent fermentation broth are disclosed 09-24-2009
31. 20090238831 MONOCLONAL ANTIBODIES AND USES THEREOF - The subject invention relates to monoclonal antibodies that may be used for example in the prevention 09-24-2009
32. 20090238766 BIOLUMINESCENT CONSTRUCT - construct comprising an amino acid sequence attached to a luciferin substrate 09-24-2009
33. 20090238436 COMPOSITION FOR IMAGING REAGENT - composition comprising a buffer and an aminoluciferase bioluminescent imaging reagent 09-24-2009
34. 20090233953 ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USES THEREOF 09-17-2009
35. 20090232801 Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof 09-17-2009
36. 20090232797 PLASMODIUM MALARIAE AND PLASMODIUM OVALE GENES AND USES THEREOF 09-17-2009
37. 20090221648 COMPOSITIONS FOR TREATMENT OF COGNITIVE DISORDERS 09-03-2009
38. 20090220510 Specific binding proteins and uses thereof 09-03-2009
39. 20090214515 METHODS OF PREPARATION OF RECOMBINANT FORMS OF HUMAN BETA-AMYLOID PROTEIN AND USES OF THESE PROTEINS 08-27-2009
40. 20090203842 Macromolecular Conjugates And Processes For Preparing The Same 08-13-2009
41. 20090203748 NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR 08-13-2009
42. 20090203709 Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor 08-13-2009
43. 20090203690 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS 08-13-2009
44. 20090203671 METHOD OF TREATING CANCER - Methods of treating cancer in patients comprising administering thereto aurora kinase inhibitors and TRAIL -related 08-13-2009
45. 20090203664 (1S,5S)-3-(5,6-DICHLORO-3-PYRIDINYL)-3,6- DIAZABICYCLO[3.2.0]HEPTANE 08-13-2009
46. 20090203038 Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays 08-13-2009
47. 20090203037 Anti-T. Cruzi Antibodies and Methods of Use 08-13-2009
48. 20090198067 (1S,5S)-3-(5,6-Dichloropyridin-3-YL)-3,6-Diazabicyclo[3.2.0]Heptane Benzenesulfonate 08-06-2009
49. 20090197860 BIARYL SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES 08-06-2009
50. 20090192198 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-30-2009
51. 20090192186 BIARYL SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES 07-30-2009
52. 20090192141 METHODS OF USE OF INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-30-2009
53. 20090191190 Anti-ABeta Globulomer Antibodies, Antigen-Binding Moieties Thereof, Corresponding Hybridomas, Nucleic Acids, Vectors, Host Cells, Methods of Producing Said Antibodies, Compositions Comprising Said Antibodies, Uses Of Said Antibodies And Methods Of Using Said Antibodies 07-30-2009
54. 20090186912 ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: compounds and salts thereof that inter alia inhibit HCV 07-23-2009
55. 20090186877 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS 07-23-2009
56. 20090176883 TRPA1 Antagonists - Compounds of formula STR00001 wherein R 07-09-2009
57. 20090176785 METHOD OF TREATING ARTHRITIS - Methods of preventing or treating arthritis is disclosed 07-09-2009
58. 20090176784 ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: compounds and salts thereof that inter alia inhibit HCV 07-09-2009
59. 20090176783 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-09-2009
60. 20090176274 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF 07-09-2009
61. 20090175847 HUMANIZED ANTIBODIES TO AB (20-42) GLOBULOMER AND USES THEREOF 07-09-2009
62. 20090163470 THIAZOLYLIDINE UREA AND AMIDE DERIVATIVES AND METHODS OF USE THEREOF 06-25-2009
63. 20090163464 BENZOTHIAZOLE AND BENZOOXAZOLE DERIVATIVES AND METHODS OF USE 06-25-2009
64. 20090162876 MYELOPEROXIDASE ASSAYS - methods and kits for determining autoantibodies to myeloperoxidase or a myeloperoxidase fragment and myeloperoxidase or a 06-25-2009
65. 20090160654 ARTICLES CONTAINING CHIPLESS RADIO FREQUENCY IDENTIFICATION ELEMENTS 06-25-2009
66. 20090158863 AUTOMATIC LOADING OF SAMPLE TUBES FOR CLINICAL ANALYZER 06-25-2009
67. 20090149501 NOVEL INDOLES ARE CANNABINOID RECEPTOR LIGANDS 06-11-2009
68. 20090149461 METHOD OF TREATING CANCER - Methods of treating cancer using N--5 5-dimethyl-1-cyclohex-1-en-1-yl)methyl)pip- erazin-1-yl)benzoyl)-4--3--1-methyl- 06-11-2009
69. 20090148879 Stabilizing Compositions, Methods and Kits for Chemiluminescent Assays 06-11-2009
70. 20090148871 Interdependent Assays for Detecting Two or More Analytes of Interest in A Test Sample 06-11-2009
71. 20090148866 Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase 06-11-2009
72. 20090142765 METHOD AND APPARATUS FOR RAPIDLY COUNTING AND IDENTIFYING BIOLOGICAL PARTICLES IN A FLOW STREAM 06-04-2009
73. 20090137585 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS - N-Benzoyl arylsulfonamides having the formula STR00001 are BCL-Xl inhibitors and are useful for promoting 05-28-2009
74. 20090131434 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme 05-21-2009
75. 20090131425 INHIBITORS OF PROTEIN KINASES - Compounds that inhibit Aurora-kinases compositions containing the compounds and methods of treating diseases using the 05-21-2009
76. 20090131379 VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING 05-21-2009
77. 20090129990 RACK FOR SAMPLE CONTAINERS FOR CLINICAL ANALYZER 05-21-2009
78. 20090124816 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Crystalline Form 2 ways to make it formulations comprising it and made with it and methods of 05-14-2009
79. 20090124815 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Crystalline Form 1 ways to make it formulations comprising it and made with it and methods of 05-14-2009
80. 20090124671 TRPV1 ANTAGONISTS - compounds of formula STR00001 wherein X, R 05-14-2009
81. 20090124666 TRPV1 ANTAGONISTS - Compounds of formula STR00001 wherein R 05-14-2009
82. 20090124616 7-NONSUBSTITUTED INDOLE MCL-1 INHIBITORS 05-14-2009
83. 20090124022 ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF 05-14-2009
84. 20090123970 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF 05-14-2009
85. 20090123946 IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL 05-14-2009
86. 20090123945 CHOLINERGIC/SEROTONINERGIC RECEPTOR AND USES THEREOF 05-14-2009
87. 20090123473 HUMAN BNP IMMUNOSPECIFIC ANTIBODIES - antibodies that immunospecifically bind to human brain natriuretic peptide or a human brain natriuretic peptide 05-14-2009
88. 20090118344 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Hydrate Crystalline Form 1 ways to make it formulations comprising it and made with it and methods 05-07-2009
89. 20090117620 AUTOMATED ANALYZER FOR CLINICAL LABORATORY 05-07-2009
90. 20090117004 SYSTEM FOR AUTOMATICALLY LOADING IMMUNOASSAY ANALYZER 05-07-2009
91. 20090111133 Gel Filtration Standard - suitable for use as molecular weight markers for gel filtration chromatography for a mobile phase with denaturant 04-30-2009
92. 20090111123 COMPOSITIONS FOR DETECTING ANTIBODIES TO BABESIA MICROTI AND METHODS OF USES THEREOF 04-30-2009
93. 20090105715 BONE FIXATION TENSIONING TOOL AND METHOD 04-23-2009
94. 20090105486 Crystalline Chemotherapeutic - N-phenyl)-N'-urea Tolueneate Crystalline Form 1, ways to make it and ways to use it are disclosed 04-23-2009
95. 20090105326 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea1/4 Ethanolate Crystalline Form 1 ways to make it formulations comprising it and made with it and 04-23-2009
96. 20090105306 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 04-23-2009
97. 20090105304 COMBINATION THERAPY FOR REDUCING SIDE EFFECTS USING CANNABINOID RECEPTOR LIGANDS 04-23-2009
98. 20090105267 OCTAHYDRO-PYRROLO[3,4-B]PYRROLE N-OXIDES 04-23-2009
99. 20090104712 HEPATITIS B PRE-S2 NUCLEIC ACID - This invention relates to a nucleic acid molecule encoding a middle Hepatitis B virus surface protein 04-23-2009
100. 20090104634 ONE-STEP IMMUNOASSAYS EXHIBITING INCREASED SENSITIVITY AND SPECIFICITY 04-23-2009
101. 20090104632 MODIFIED TWO-STEP IMMUNOASSAY EXHIBITING INCREASED SENSITIVITY 04-23-2009
102. 20090099246 2-{(R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2 04-16-2009
103. 20090099245 2-{(R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1 04-16-2009
104. 20090098531 DETECTING HEPATITIS B VIRUS - This invention is related to methods for detecting hepatitis B virus by determining the level of hepatitis B virus surface 04-16-2009
105. 20090082325 Cefidinir Oral Suspension - novel powder for oral suspension of cefdinir 03-26-2009
106. 20090069275 LOW FLUSH NIACIN FORMULATION - extended-release matrix formulation capable of being directly compressed into tablets comprising niacin 03-12-2009
107. 20090068635 INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME 03-12-2009
108. 20090062345 AMIDE DERIVATIVES AS TRPV1 ANTAGONISTS - compounds of formula or pharmaceutically acceptable salts prodrugs 03-05-2009
109. 20090054499 Intermediate Release Nicotinic Acid Compositions For Treating Hyperlipidemia Which Exhibit an In Vivo Stair-Stepped Absorption Curve 02-26-2009
110. 20090054430 Inhibitors of Protein Kinases - Compounds that inhibit Aurora-kinases compositions containing the compounds and methods of treating diseases using the 02-26-2009
111. 20090054426 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS 02-26-2009
112. 20090054420 BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS 02-26-2009
113. 20090054402 7-SUBSTITUTED INDOLE MCL-1 INHIBITORS - Compounds which inhibit the activity of anti-apoptotic Mcl-1 protein compositions containing the compounds 02-26-2009
114. 20090053747 Measurement of Haloperoxidase Activity With Chemiluminescent Detection 02-26-2009
115. 20090053736 Homogeneous Chemiluminescent Immunoassay for Analysis of Iron Metalloproteins 02-26-2009
116. 20090053305 Pharmaceutical Formulations - Improved pharmaceutical compositions are provided comprising one or more solubilized HIV protease inhibiting compounds 02-26-2009
117. 20090048298 Novel acetyl-CoA Carboxylase (ACC) Inhibitors and their use in Diabetes, Obesity and Metabolic Syndrome 02-19-2009
118. 20090047679 METHOD AND SYSTEM FOR ANALYZING REACTIONS USING AN INFORMATION SYSTEM 02-19-2009
119. 20090042888 Prostaglandin endoperoxide H synthase biosynthesis inhibitors 02-12-2009
120. 20090035307 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES 02-05-2009
121. 20090030196 PIM KINASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS 01-29-2009
122. 20090030016 BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS 01-29-2009
123. 20090029966 COMBINATION THERAPY WITH PARP INHIBITORS 01-29-2009
124. 20090023789 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 01-22-2009
125. 20090023743 INHIBITORS OF PROTEIN KINASES - Compounds that inhibit Aurora-kinases compositions containing the compounds and methods of treating diseases using the 01-22-2009
126. 20090022798 FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS 01-22-2009
127. 20090020662 CONTAINER SEGMENT ASSEMBLY - suitable for use with a carousel of an analytical instrument including a container rack having the shape of a rectangular 01-22-2009
128. 20090018662 INTERVERTEBRAL IMPLANT FOR THE LUMBOSACRAL JOINT 01-15-2009
129. 20090018114 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 01-15-2009
130. 20090017560 CARDIOVASCULAR AUTOIMMUNE DISEASE PANEL AND METHODS OF USING SAME 01-15-2009
131. 20090005815 DYNAMIC STABILIZATION SYSTEM - Embodiments of the disclosure provide a device and system for dynamic spinal stabilization 01-01-2009
132. 20090005814 STABILIZATION SYSTEM AND METHOD - The disclosure relates generally to embodiments of systems and methods of spinal stabilization 01-01-2009
133. 20090005813 APPARATUS AND METHODS FOR SPINAL IMPLANTS 01-01-2009
134. 20090005787 DEVICE AND SYSTEM FOR IMPLANTING POLYAXIAL BONE FASTENERS 01-01-2009
135. 20080319432 SURGICAL ILLUMINATION SYSTEM AND METHOD - The disclosure describes embodiments of systems and methods for surgical illumination, particularly for spinal 12-25-2008
136. 20080312698 DEVICE AND SYSTEM FOR STABILIZING MOVEMENT BETWEEN BONY TISSUE AND METHOD FOR IMPLANTING 12-18-2008
137. 20080312694 DYNAMIC STABILIZATION ROD FOR SPINAL IMPLANTS AND METHODS FOR MANUFACTURING THE SAME 12-18-2008
138. 20080312458 Reactivity of Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors Containing Conjugated Dienes with Phenolic Antioxidants in the Solid-State 12-18-2008
139. 20080312282 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme 12-18-2008
140. 20080312214 Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme 12-18-2008
141. 20080311676 IMMUNOASSAYS EXHIBITING REDUCED CROSS-REACTIVITY WITH HYDROPHOBIC DRUG ANALYTE METABOLITES 12-18-2008
142. 20080308600 DEVICE AND SYSTEM FOR APPLYING ROTARY IMPACT 12-18-2008
143. 20080305512 ASSAY FOR CARDIAC TROPONIN AUTOANTIBODIES 12-11-2008
144. 20080300789 Method for determining the order of execution of assays of a sample in a laboratory automation system 12-04-2008
145. 20080300634 SPINAL INTERBODY SYSTEM AND METHOD - Embodiments of the present invention provide spinal implant systems and methods 12-04-2008
146. 20080299583 METHOD AND SYSTEM FOR ANALYZING REACTIONS USING AN INFORMATION SYSTEM 12-04-2008
147. 20080299567 PRIMER AND PROBE SEQUENCES FOR DETECTING CHLAMYDIA TRACHOMATIS 12-04-2008
148. 20080299203 Solid Pharmaceutical Dosage Formulation - pharmaceutical dosage formulation and more particularly a pharmaceutical dosage formulation comprising an HIV 12-04-2008
149. 20080294260 SPINAL IMPLANT SYSTEM AND METHOD - Embodiments of the present invention provide a spinal implant system and method 11-27-2008
150. 20080293795 COMBINATION THERAPY WITH PARP INHIBITORS 11-27-2008
151. 20080293713 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme 11-27-2008
152. 20080288002 Spinal Stabilization Systems and Methods 11-20-2008
153. 20080287676 FUSED COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR 11-20-2008
154. 20080287510 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 11-20-2008
155. 20080287419 APOPTOSIS PROMOTERS - Compounds which inhibit the activity of anti-apoptotic family protein members compositions containing the compounds and methods of 11-20-2008
156. 20080286818 BLOOD SAMPLE HANDLING METHODS FOR IMPROVED ASSAYS FOR MYELOPEROXIDASE 11-20-2008
157. 20080281362 DEVICE AND SYSTEM FOR CRANIAL SUPPORT - device and system for supporting the cranium, and a method for manufacturing 11-13-2008
158. 20080280867 COMBINATION THERAPY WITH PARP INHIBITORS 11-13-2008
159. 20080280377 HUMAN B-TYPE NATRIURETIC PEPTIDE ASSAY HAVING REDUCED CROSS-REACTIVITY WITH OTHER PEPTIDE FORMS 11-13-2008
160. 20080279859 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF 11-13-2008
161. 20080275048 Substituted Diazabicycloalkane Derivates 11-06-2008
162. 20080269897 IMPLANTABLE DEVICE AND METHODS FOR REPAIRING ARTICULATING JOINTS FOR USING THE SAME 10-30-2008
163. 20080269236 Novel 1,2,4 Oxadiazole Compounds and Methods of Use Thereof 10-30-2008
164. 20080269234 INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE 10-30-2008
165. 20080268056 INJECTABLE COPOLYMER HYDROGEL USEFUL FOR REPAIRING VERTEBRAL COMPRESSION FRACTURES 10-30-2008
166. 20080264894 CONTAINER CLOSURE ASSEMBLY - assembly comprising a container and a closure 10-30-2008
167. 20080262023 Aminomethyl Azaadamantane Derivatives and Methods of Use Thereof 10-23-2008
168. 20080255203 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE 10-16-2008
169. 20080255180 4-Substituted Azaadamantane Derivatives and Methods of Use Thereof 10-16-2008
170. 20080255179 Acetamide and Carboxamide Derivatives of Azaadamantane and Methods of Use Thereof 10-16-2008
171. 20080255178 Azaadamantane Ester and Carbamate Derivatives and Methods of Use Thereof 10-16-2008
172. 20080255123 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 10-16-2008
173. 20080249622 INTERBODY IMPLANT - includes first and second members that are configured to allow the members to be inserted into a disc space separately and then 10-09-2008
174. 20080248579 Method of stabilizing human natriuretic peptides 10-09-2008
175. 20080248493 ACRIDINIUM PHENYL ESTERS USEFUL IN THE ANALYSIS OF BIOLOGICAL SAMPLES 10-09-2008
176. 20080248491 BIOMARKER FRAGMENTS FOR THE DETECTION OF HUMAN BNP 10-09-2008
177. 20080242654 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 10-02-2008
178. 20080242653 Cyclopropyl amine derivatives - Compounds of formula wherein R 10-02-2008
179. 20080234735 SPINAL IMPLANT FOR FACET JOINT - apparatus and method are provided for supporting an adjacent pair of vertebra relative to each other by anchoring a 09-25-2008
180. 20080234311 IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES 09-25-2008
181. 20080234308 Amino-Aza-Adamantane Derivatives and Methods of Use 09-25-2008
182. 20080227805 SUSTAINED RELEASE PARENTERAL FORMULATIONS OF BUPRENORPHINE 09-18-2008
183. 20080220448 ANTIGENIC PROTEIN CONJUGATES AND PROCESS FOR PREPARING SAME 09-11-2008
184. 20080214528 ANTI-INFECTIVE AGENTS - HCV polymerase inhibiting compounds having the formula : where R 09-04-2008
185. 20080214524 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR 09-04-2008
186. 20080213797 IMMUNOASSAYS EXHIBITING A REDUCTION IN PROZONE PHENOMENA 09-04-2008
187. 20080210231 METERED DOSE INHALER CLEANING METHOD AND APPARATUS 09-04-2008
188. 20080206339 VERY-PURE SUPERPOROUS HYDROGELS HAVING OUTSTANDING SWELLING PROPERTIES 08-28-2008
189. 20080203193 NOZZLE-BASED ATOMIZATION SYSTEM - improved atomization system for aerosolizing liquids including a vortexing nozzle and a flat or protruding face on the 08-28-2008
190. 20080199873 Companion diagnostic assays for cancer therapy 08-21-2008